Come up with a name for your new list and we'll add to it:
Pathway Therapeutics raised a round of funding on December 19, 2008. Investors include
Trans Tasman Commercialisation Fund.
Pathway Therapeutics is a clinical stage, privately held, pharmaceutical company developing differentiated isoform specific PI3-kinase (PI3K) inhibitors for oncology, inflammatory and respiratory dise…